Cyclo Therapeutics, Inc. is a biotechnology company that develops cyclodextrin-based products for the treatment of disease. The company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C, a rare and fatal genetic disease, on a compassionate use basis as well as in three ongoing formal clinical trials (Clinical Trials.gov NCT02939547, NCT02912793 and NCT03893071). Additional indications for the active ingredient in Trappsol® Cyclo™ are in development. is a family of biotechnology growth companies based on cyclodextrin chemistry.
||P.O. Box 1180, Alachua, FL 32616
||Drug Related Products
||Medicinal and Botanical Manufacturing (325411)
||Medicinal Chemicals And Botanical Products (2833)